Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Clonal anergy
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
==Testing== The "Multitest Mérieux" or "CMI Multitest" system (Multitest IMC, Istituto Merieux Italia, Rome, Italy) has been used as a general test of the level of [[cellular immunity]]. It is an [[intradermal]] test of [[skin reactivity]] (similar to [[tuberculin test]]s) in which a control ([[glycerol]]) is used with seven antigens of bacterial or fungal origin ([[tetanus toxoid]], [[tuberculin]], [[diphtheria]], [[streptococcus]], [[Candida (genus)|candida]], [[trichophyton]], and [[Proteus (bacterium)|proteus]]). In this test reactions are categorized according to the number of antigens provoking a response and the summed extent of the skin response to all seven antigens. Here '''anergy''' is defined as a region of skin reactivity of 0–1 mm, '''hypoergy''' as a reaction of 2–9 mm in response to fewer than three antigens, '''normergic''' as a reaction of 10–39 mm or to three or more antigens, and '''hyperergy''' for a reaction of 40 mm or more.<ref name="Muller et al">{{cite journal | vauthors = Müller N, Schneider T, Zeitz M, Marth T |year=2001 |title=Whipple's disease: new aspects in pathogenesis and diagnoses |url=http://documents.irevues.inist.fr/bitstream/2042/7452/1/actaend_2001_3_243-253.pdf |journal=Acta Endoscopica |volume=31 |pages=243–253 |doi=10.1007/BF03020891 |s2cid=30195122 }}</ref><ref name="Spornraft et al">{{cite journal | vauthors = Spornraft P, Fröschl M, Ring J, Meurer M, Goebel FD, Ziegler-Heitbrock HW, Riethmüller G, Braun-Falco O | display-authors = 6 | title = T4/T8 ratio and absolute T4 cell numbers in different clinical stages of Kaposi's sarcoma in AIDS | journal = The British Journal of Dermatology | volume = 119 | issue = 1 | pages = 1–9 | date = July 1988 | pmid = 3261596 | doi = 10.1111/j.1365-2133.1988.tb07095.x | url = http://www.rethinkingaids.com/portals/0/TheCD/S/spo.pdf | url-status = dead | s2cid = 29214452 | archive-url = https://web.archive.org/web/20110611232418/http://www.rethinkingaids.com/portals/0/TheCD/S/spo.pdf | archive-date = 2011-06-11 }}</ref><ref name="De Flora et al">{{cite journal | vauthors = De Flora S, Grassi C, Carati L | title = Attenuation of influenza-like symptomatology and improvement of cell-mediated immunity with long-term N-acetylcysteine treatment | journal = The European Respiratory Journal | volume = 10 | issue = 7 | pages = 1535–1541 | date = July 1997 | pmid = 9230243 | doi = 10.1183/09031936.97.10071535 | doi-access = free }}</ref>
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)